DOI QR코드

DOI QR Code

Hyaluronic acid reduces inflammation and crevicular fluid IL-1β concentrations in peri-implantitis: a randomized controlled clinical trial

  • Sanchez-Fernandez, Elena (Department of Oral Surgery and Implant Dentistry, School of Dentistry, University of Granada) ;
  • Magan-Fernandez, Antonio (Department of Periodontics, School of Dentistry, University of Granada) ;
  • O'Valle, Francisco (Department of Pathology and History of Science, School of Medicine, University of Granada) ;
  • Bravo, Manuel (Department of Preventive and Community Dentistry, School of Dentistry, University of Granada) ;
  • Mesa, Francisco (Department of Periodontics, School of Dentistry, University of Granada)
  • Received : 2019.07.17
  • Accepted : 2020.09.28
  • Published : 2021.02.28

Abstract

Purpose: This study investigated the effects of hyaluronic acid (HA) on peri-implant clinical variables and crevicular concentrations of the proinflammatory biomarkers interleukin (IL)-1β and tumor necrosis factor (TNF)-α in patients with peri-implantitis. Methods: A randomized controlled trial was conducted in peri-implantitis patients. Patients were randomized to receive a 0.8% HA gel (test group), an excipient-based gel (control group 1), or no gel (control group 2). Clinical periodontal variables and marginal bone loss after 0, 45, and 90 days of treatment were assessed. IL-1β and TNF-α levels in crevicular fluid were measured by enzyme-linked immunosorbent assays at baseline and after 45 days of treatment. Clustering analysis was performed, considering the possibility of multiple implants in a single patient. Results: Sixty-one patients with 100 dental implants were assigned to the test group, control group 1, or control group 2. Probing pocket depth (PPD) was significantly lower in the test group than in both control groups at 45 days (control 1: 95% CI, -1.66, -0.40 mm; control 2: 95% CI, -1.07, -0.01 mm) and 90 days (control 1: 95% CI, -1.72, -0.54 mm; control 2: 95% CI, -1.13, -0.15 mm). There was a trend towards less bleeding on probing in the test group than in control group 2 at 90 days (P=0.07). Implants with a PPD ≥5 mm showed higher levels of IL-1β in the control group 2 at 45 days than in the test group (P=0.04). Conclusions: This study demonstrates for the first time that the topical application of a HA gel in the peri-implant pocket and around implants with peri-implantitis may reduce inflammation and crevicular fluid IL-1β levels.

Keywords

Acknowledgement

The authors are grateful to Richard Davies for editorial assistance.

References

  1. Dahiya P, Kamal R. Hyaluronic acid: a boon in periodontal therapy. N Am J Med Sci 2013;5:309-15. https://doi.org/10.4103/1947-2714.112473
  2. Sutherland IW. Novel and established applications of microbial polysaccharides. Trends Biotechnol 1998;16:41-6. https://doi.org/10.1016/S0167-7799(97)01139-6
  3. Moreland LW. Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Res Ther 2003;5:54-67. https://doi.org/10.1186/ar623
  4. Chen WY, Abatangelo G. Functions of hyaluronan in wound repair. Wound Repair Regen 1999;7:79-89. https://doi.org/10.1046/j.1524-475X.1999.00079.x
  5. Berglundh T, Armitage G, Araujo MG, Avila-Ortiz G, Blanco J, Camargo PM, et al. Peri-implant diseases and conditions: consensus report of workgroup 4 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Clin Periodontol 2018;45 Suppl 20:S286-91. https://doi.org/10.1111/jcpe.12957
  6. Smith AJ, Addy M, Embery G. Gingival crevicular fluid glycosaminoglycan levels in patients with chronic adult periodontitis. J Clin Periodontol 1995;22:355-61. https://doi.org/10.1111/j.1600-051X.1995.tb00161.x
  7. Manzanares D, Monzon ME, Savani RC, Salathe M. Apical oxidative hyaluronan degradation stimulates airway ciliary beating via RHAMM and RON. Am J Respir Cell Mol Biol 2007;37:160-8. https://doi.org/10.1165/rcmb.2006-0413OC
  8. Duarte PM, Serrao CR, Miranda TS, Zanatta LC, Bastos MF, Faveri M, et al. Could cytokine levels in the peri-implant crevicular fluid be used to distinguish between healthy implants and implants with periimplantitis? A systematic review. J Periodontal Res 2016;51:689-98. https://doi.org/10.1111/jre.12354
  9. Casale M, Moffa A, Vella P, Sabatino L, Capuano F, Salvinelli B, et al. Hyaluronic acid: Perspectives in dentistry. A systematic review. Int J Immunopathol Pharmacol 2016;29:572-82. https://doi.org/10.1177/0394632016652906
  10. Soriano-Lerma A, Magan-Fernandez A, Gijon J, Sanchez-Fernandez E, Soriano M, Garcia-Salcedo JA, et al. Short-term effects of hyaluronic acid on the subgingival microbiome in peri-implantitis: a randomized controlled clinical trial. J Periodontol 2020;91:734-45. https://doi.org/10.1002/JPER.19-0184
  11. Lopez MA, Manzulli N, D'Angelo A, Lauritano D, Papalia R, Candotto V. The use of hyaluronic acid as an adjuvant in the management of peri-implantitis. J Biol Regul Homeost Agents 2017;31:123-7.
  12. Schulz KF, Altman DG, Moher DCONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol 2010;63:834-40. https://doi.org/10.1016/j.jclinepi.2010.02.005
  13. Coli P, Christiaens V, Sennerby L, Bruyn H. Reliability of periodontal diagnostic tools for monitoring periimplant health and disease. Periodontol 2000 2017;73:203-17. https://doi.org/10.1111/prd.12162
  14. Cohen J. Statistical power analysis for the behavioural sciences. 2nd ed. New Jersey: Lawrence Erlbaum Associates; 1988.
  15. Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque. Int Dent J 1975;25:229-35.
  16. Zweers J, van Doornik A, Hogendorf EA, Quirynen M, Van der Weijden GA. Clinical and radiographic evaluation of narrow- vs. regular-diameter dental implants: a 3-year follow-up. A retrospective study. Clin Oral Implants Res 2015;26:149-56.
  17. Mombelli A, McNabb H, Lang NP. Black-pigmenting gram-negative bacteria in periodontal disease. I. Topographic distribution in the human dentition. J Periodontal Res 1991;26:301-7. https://doi.org/10.1111/j.1600-0765.1991.tb02067.x
  18. Crespi R, Marconcini S, Crespi G, Giammarinaro E, Menchini Fabris GB, Barone A, et al. Nonsurgical treatment of peri-implantitis without eliminating granulation tissue: a 3-year study. Implant Dent 2019;28:4-10. https://doi.org/10.1097/ID.0000000000000832
  19. Astasov-Frauenhoffer M, Braissant O, Hauser-Gerspach I, Weiger R, Walter C, Zitzmann NU, et al. Microcalorimetric determination of the effects of amoxicillin, metronidazole, and their combination on in vitro biofilm. J Periodontol 2014;85:349-57. https://doi.org/10.1902/jop.2013.120733
  20. Klockars AJ, Sax G. Multiple comparisons. Beverly Hills: Sage Publications Inc.; 1986.
  21. Altman DG. Practical statistics for medical research. London: Chapman & Hall; 1991.
  22. Renvert S, Lindahl C, Roos Jansaker AM, Persson GR. Treatment of peri-implantitis using an Er:YAG laser or an air-abrasive device: a randomized clinical trial. J Clin Periodontol 2011;38:65-73. https://doi.org/10.1111/j.1600-051X.2010.01646.x
  23. de Araujo Nobre M, Cintra N, Malo P. Peri-implant maintenance of immediate function implants: a pilot study comparing hyaluronic acid and chlorhexidine. Int J Dent Hyg 2007;5:87-94. https://doi.org/10.1111/j.1601-5037.2007.00239.x
  24. Goto M, Hanyu T, Yoshio T, Matsuno H, Shimizu M, Murata N, et al. Intra-articular injection of hyaluronate (SI-6601D) improves joint pain and synovial fluid prostaglandin E2 levels in rheumatoid arthritis: a multicenter clinical trial. Clin Exp Rheumatol 2001;19:377-83.
  25. Takahashi K, Goomer RS, Harwood F, Kubo T, Hirasawa Y, Amiel D. The effects of hyaluronan on matrix metalloproteinase-3 (MMP-3), interleukin-1β (IL-1β), and tissue inhibitor of metalloproteinase-1 (TIMP-1) gene expression during the development of osteoarthritis. Osteoarthritis Cartilage 1999;7:182-90. https://doi.org/10.1053/joca.1998.0207
  26. Sasaki A, Sasaki K, Konttinen YT, Santavirta S, Takahara M, Takei H, et al. Hyaluronate inhibits the interleukin-1β-induced expression of matrix metalloproteinase (MMP)-1 and MMP-3 in human synovial cells. Tohoku J Exp Med 2004;204:99-107. https://doi.org/10.1620/tjem.204.99
  27. Nonaka T, Kikuchi H, Ikeda T, Okamoto Y, Hamanishi C, Tanaka S. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis. J Rheumatol 2000;27:997-1004.
  28. Wang CT, Lin YT, Chiang BL, Lin YH, Hou SM. High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis. Osteoarthritis Cartilage 2006;14:1237-47. https://doi.org/10.1016/j.joca.2006.05.009
  29. Bourguignon LY, Wong G, Earle CA, Xia W. Interaction of low molecular weight hyaluronan with CD44 and toll-like receptors promotes the actin filament-associated protein 110-actin binding and MyD88-NFκB signaling leading to proinflammatory cytokine/chemokine production and breast tumor invasion. Cytoskeleton (Hoboken) 2011;68:671-93. https://doi.org/10.1002/cm.20544
  30. Johnson P, Maiti A, Brown KL, Li R. A role for the cell adhesion molecule CD44 and sulfation in leukocyteendothelial cell adhesion during an inflammatory response? Biochem Pharmacol 2000;59:455-65. https://doi.org/10.1016/S0006-2952(99)00266-X
  31. Siegelman MH, Stanescu D, Estess P. The CD44-initiated pathway of T-cell extravasation uses VLA-4 but not LFA-1 for firm adhesion. J Clin Invest 2000;105:683-91. https://doi.org/10.1172/JCI8692
  32. Mesa FL, Aneiros J, Cabrera A, Bravo M, Caballero T, Revelles F, et al. Antiproliferative effect of topic hyaluronic acid gel. Study in gingival biopsies of patients with periodontal disease. Histol Histopathol 2002;17:747-53.
  33. Eliezer M, Imber JC, Sculean A, Pandis N, Teich S. Hyaluronic acid as adjunctive to non-surgical and surgical periodontal therapy: a systematic review and meta-analysis. Clin Oral Investig 2019;23:3423-35. https://doi.org/10.1007/s00784-019-03012-w
  34. Alcantara CE, Castro MA, Noronha MS, Martins-Junior PA, Mendes RM, Caliari MV, et al. Hyaluronic acid accelerates bone repair in human dental sockets: a randomized triple-blind clinical trial. Braz Oral Res 2018;32:e84.
  35. Faot F, Nascimento GG, Bielemann AM, Campao TD, Leite FR, Quirynen M. Can peri-implant crevicular fluid assist in the diagnosis of peri-implantitis? A systematic review and meta-analysis. J Periodontol 2015;86:631-45. https://doi.org/10.1902/jop.2015.140603
  36. Sanz M, Chapple IL; Working Group 4 of the VIII European Workshop on Periodontology. Clinical research on peri-implant diseases: consensus report of Working Group 4. J Clin Periodontol 2012;39 Suppl 12:202-6. https://doi.org/10.1111/j.1600-051X.2011.01837.x
  37. Derks J, Tomasi C. Peri-implant health and disease. A systematic review of current epidemiology. J Clin Periodontol 2015;42 Suppl 16:S158-71. https://doi.org/10.1111/jcpe.12334
  38. Ata-Ali J, Flichy-Fernandez AJ, Alegre-Domingo T, Ata-Ali F, Penarrocha-Diago M. Impact of heavy smoking on the clinical, microbiological and immunological parameters of patients with dental implants: a prospective cross-sectional study. J Investig Clin Dent 2016;7:401-9. https://doi.org/10.1111/jicd.12176

Cited by

  1. Surface Treatment of the Dental Implant with Hyaluronic Acid: An Overview of Recent Data vol.18, pp.9, 2021, https://doi.org/10.3390/ijerph18094670
  2. Hyaluronan as a Prominent Biomolecule with Numerous Applications in Medicine vol.22, pp.13, 2021, https://doi.org/10.3390/ijms22137077